In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Centessa Pharmaceuticals plc ADR’s stock clocked out at $14.38, down -1.44% from its previous closing price of $14.59. In other words, the price has decreased by -$1.44 from its previous closing price. On the day, 0.86 million shares were traded. CNTA stock price reached its highest trading level at $14.89 during the session, while it also had its lowest trading level at $13.75.
Ratios:
To gain a deeper understanding of CNTA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.25 and its Current Ratio is at 9.25. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 31, 2025, initiated with a Overweight rating and assigned the stock a target price of $38.
Morgan Stanley Upgraded its Equal-Weight to Overweight on September 20, 2024, whereas the target price for the stock was revised from $11 to $26.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when Weinhoff Gregory M sold 10,000 shares for $16.34 per share. The transaction valued at 163,386 led to the insider holds 134,021 shares of the business.
Weinhoff Gregory M bought 10,000 shares of CNTA for $165,300 on Mar 25 ’25. On Mar 20 ’25, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $16.69 each. As a result, the insider received 918,060 and left with 276,017 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 1937762560 and an Enterprise Value of 1550841984.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.52, which has changed by 0.26919687 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is -12.44%, while the 200-Day Moving Average is calculated to be -2.06%.
Shares Statistics:
It appears that CNTA traded 882.92K shares on average per day over the past three months and 1023710 shares per day over the past ten days. A total of 132.63M shares are outstanding, with a floating share count of 80.34M. Insiders hold about 39.43% of the company’s shares, while institutions hold 54.79% stake in the company. Shares short for CNTA as of 1741910400 were 4864841 with a Short Ratio of 5.51, compared to 1739491200 on 4153707. Therefore, it implies a Short% of Shares Outstanding of 4864841 and a Short% of Float of 4.32.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
